LEP and prostate carcinoma: Overexpressed miRNA‐628 could dampen the proliferation of prostate cancer cells and reduce EMT, invasive ability, and the characteristics of stem cells, while leptin can promote the development of prostate cancer by downregulating the expression of miRNA‐628.154